circRNA basic information
circBase ID: hsa_circ_0091570
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chrX:131516205-131526362:-
Genomic location(hg38): chrX:132382177-132392334:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; matched para-carcinoma normal tissues; matched non-tumor tissues; tumor tissues; xenografts tumor; lung metastatic nodules

Cell lines:

HepG2; SMMC-7721; LO2; 7402; 97H; SMMC-LTNM

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: ISM1, AGO2
Associated microRNA: miR-1307
Biological function: hsa_circ_0091570 suppresses HCC cell proliferation, migration, invasion, metastasis and tumor growth, and promotes apoptosis; knockdown of hsa_circ_0091570 has the opposite effects.
Molecular mechanism: hsa_circ_0091570 acts as a ceRNA/miRNA sponge for miR-1307, thereby protecting or up-regulating ISM1 expression and suppressing HCC progression.
Biological pathway or process:

ceRNA regulation (promotes); proliferation (inhibits); apoptosis (promotes); cell cycle (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits)

Detected method:
Q
M
Validation methods:

Microarray; RT-qPCR; RNase R Treatment; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Survival Analysis; Transfection; CCK8; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; RNA Pull-Down; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Western Blot; FISH / smFISH; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); ELISA

Clinical significance:

Decreased hsa_circ_0091570 expression is associated with pathological staging, high Edmondson Grade and portal vein tumor thrombus in HCC patients; ROC analysis showed potential diagnostic capability; hsa_circ_0091570 was related to overall survival rates and may be a prognostic biomarker and therapeutic target.

Description:

hsa_circ_0091570 is down-regulated in HCC tissues and cell lines and functions as a tumor suppressor. It sponges miR-1307 as a ceRNA to regulate ISM1 expression, thereby inhibiting HCC proliferation, migration, invasion, metastasis and tumor growth while promoting apoptosis. Clinically, reduced hsa_circ_0091570 expression is associated with pathological progression, diagnostic potential and prognosis in HCC patients.

Confidence score:

0.8824

Other information
Title:

hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.

Journal: Cancer letters
Published: 2019
PubMed ID: 31207319
Study type:

combined biological and clinical study

Data availability: GSE97332; GPL19978
Code availability: -